# Chlordiazepoxide
*Source: https://go.drugbank.com/drugs/DB00475*

## Overview

### Description

This compound belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine.

### Background

An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.

### Indication

Chlordiazepoxide is indicated for the management of anxiety disorders or for the short-term relief of symptoms of anxiety, withdrawal symptoms of acute alcoholism, and preoperative apprehension and anxiety.
8
In combination with amitriptyline, chlordiazepoxide is indicated for the treatment of moderate to severe depression.
7
In combination with clidinium, chlordiazepoxide is indicated to control emotional and somatic factors in gastrointestinal disorders, and is used as adjunctive therapy in the treatment of peptic ulcer, irritable bowel syndrome and acute enterocolitis.
6

### Pharmacodynamics

Chlordiazepoxide has antianxiety, sedative, appetite-stimulating and weak analgesic actions. The drug seems to block EEG arousal from stimulation in the brain stem reticular formation. The drug has been studied extensively in many species of animals and these studies are suggestive of action on the limbic system of the brain, which recent evidence indicates is involved in emotional responses. Hostile monkeys were made tame by oral drug doses which did not cause sedation. Chlordiazepoxide revealed a "taming" action with the elimination of fear and aggression. The taming effect of chlordiazepoxide was further demonstrated in rats made vicious by lesions in the septal area of the brain. The drug dosage which effectively blocked the vicious reaction was well below the dose which caused sedation in these animals.

### Mechanism of Action

GABA(A) Receptor
Positive allosteric modulator
GABA(A) Receptor Benzodiazepine Binding Site
Ligand

### Metabolism

Hepatic.

### Half-life

24-48 hours

### Toxicity

LD
50
=537 mg/kg (Orally in rats). Signs of overdose include respiratory depression, muscle weakness, somnolence (general depressed activity).

### Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

1,2-Benzodiazepine
The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with 1,2-Benzodiazepine.
Acetazolamide
The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Acetazolamide.
Acetophenazine
The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Acetophenazine.
Agomelatine
The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Agomelatine.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Chlordiazepoxide.

### Food Interactions

Avoid alcohol.
Take with or without food. The absorption is unaffected by food.

## Chemical Information

**DrugBank ID:** DB00475

**Synonyms:** 7-chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepin-4-oxide
CDP
Chloradiazepoxide
Chlordiazepoxide
Chlordiazepoxidum
Clopoxide
Clordiazepóxido
Methaminodiazepoxide

**Chemical Formula:** C
16
H
14
ClN
3
O

**SMILES:** CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1

**Weight:** Average: 299.755
Monoisotopic: 299.082539792

**IUPAC Name:** 7-chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepin-4-ium-4-olate

## Additional Information

### Modality

Small Molecule

### Patents

0

### Indicated Conditions

8

### Phase 0

0

### Phase 1

0

### Phase 2

1

### Phase 3

2

### Phase 4

2

### Therapeutic Categories

Benzodiazepines and benzodiazepine
derivatives

### Summary

Chlordiazepoxide
is a benzodiazepine used to treat the withdrawal symptoms of acute alcoholism, to treat preoperative anxiety, and to treat anxiety over a short term period.

### Brand Names

Chlorax, Librax

### Generic Name

Chlordiazepoxide

### DrugBank Accession Number

DB00475

### Groups

Approved, Illicit, Investigational

### Structure

Download
MOL
SDF
PDB
SMILES
InChI
Similar Structures
Structure for Chlordiazepoxide (DB00475)
×
Close

### Associated Conditions

Indication Type
Indication
Combined Product Details
Approval Level
Age Group
Patient Characteristics
Dose Form
Management of
Alcohol withdrawal syndrome
••••••••••••
Create Account
Management of
Anxiety disorders
••••••••••••
Create Account
Used in combination to manage
Depression
Combination Product in combination with:
Amitriptyline (DB00321)
••••••••••••
Create Account
•••••••• •• •••••• ••••••••
Used as adjunct in combination to manage
Irritable bowel syndrome (ibs)
Combination Product in combination with:
Clidinium (DB00771)
••••••••••••
Create Account
Used as adjunct in combination to manage
Peptic ulcer disease
Combination Product in combination with:
Clidinium (DB00771)
••••••••••••
Create Account
Create Account

### Mechanism of action

Chlordiazepoxide binds to stereospecific benzodiazepine (BZD) binding sites on GABA (A) receptor complexes at several sites within the central nervous system, including the limbic system and reticular formation. This results in an increased binding of the inhibitory neurotransmitter GABA to the GABA(A) receptor. BZDs, therefore, enhance GABA-mediated chloride influx through GABA receptor channels, causing membrane hyperpolarization. The net neuro-inhibitory effects result in the observed sedative, hypnotic, anxiolytic, and muscle relaxant properties.
Target
Actions
Organism
A
GABA(A) Receptor
positive allosteric modulator
Humans
A
GABA(A) Receptor Benzodiazepine Binding Site
ligand
Humans
U
Translocator protein
modulator
Humans

### Route of elimination

Chlordiazepoxide is excreted in the urine, with 1% to 2% unchanged and 3% to 6% as conjugate.

### Product Ingredients

Ingredient
UNII
CAS
InChI Key
Chlordiazepoxide hydrochloride
MFM6K1XWDK
438-41-5
DMLFJMQTNDSRFU-UHFFFAOYSA-N

### Product Images

Previous
Next

### International/Other Brands

Angirex
/
Elenium (Polfa Tarchomin)
/
Helogaphen
/
Klopoxid (Nycomed)
/
Libritabs
/
Multum
/
Napoton
/
Radepur (AWD)
/
Risolid (Actavis)
/
Silibrin
/
Sonimen
/
Tropium

### Brand Name Prescription Products

Name
Dosage
Strength
Route
Labeller
Marketing Start
Marketing End
Region
Image
Chlordiazepoxide
Capsule
25 mg
Oral
Aa Pharma Inc
1981-12-31
Not applicable
Canada
Chlordiazepoxide
Capsule
10 mg
Oral
Aa Pharma Inc
1981-12-31
Not applicable
Canada
Chlordiazepoxide
Capsule
5 mg
Oral
Aa Pharma Inc
1981-12-31
Not applicable
Canada
Chlordiazepoxide Cap 10mg
Capsule
10 mg / cap
Oral
Pro Doc Limitee
1969-12-31
2010-07-13
Canada
Chlordiazepoxide Cap 5mg
Capsule
5 mg / cap
Oral
Pro Doc Limitee
1976-12-31
2009-07-23
Canada

### Generic Prescription Products

Name
Dosage
Strength
Route
Labeller
Marketing Start
Marketing End
Region
Image
Chlordiazepoxide
Capsule, gelatin coated
25 mg/1
Oral
Direct Rx
2016-03-04
Not applicable
US
Chlordiazepoxide
Capsule
25 mg/1
Oral
Direct Rx
2016-03-04
2016-03-28
US
Chlordiazepoxide Hydrochloride
Capsule
10 mg/1
Oral
Mylan Institutional Inc.
2022-05-26
Not applicable
US
Chlordiazepoxide Hydrochloride
Capsule
25 mg/1
Oral
Rpk Pharmaceuticals, Inc.
1976-07-01
2024-12-31
US
Chlordiazepoxide Hydrochloride
Capsule
25 mg/1
Oral
Avera McKennan Hospital
2016-04-25
2017-05-24
US

### Mixture Products

Name
Ingredients
Dosage
Route
Labeller
Marketing Start
Marketing End
Region
Image
AA PHARMA CHLORAX CAPSULE
Chlordiazepoxide hydrochloride
(5 mg)
+
Clidinium Bromide
(2.5 mg)
Capsule
Oral
PHARMAFORTE SINGAPORE PTE LTD
1989-07-06
Not applicable
Singapore
CHLOBAX TABLET
Chlordiazepoxide
(5 mg)
+
Clidinium Bromide
(2.5 mg)
Tablet, sugar coated
Oral
BEACONS PHARMACEUTICALS PTE. LTD.
1996-04-19
Not applicable
Singapore
Chlorax
Chlordiazepoxide hydrochloride
(5 mg)
+
Clidinium Bromide
(2.5 mg)
Capsule
Oral
Aa Pharma Inc
1984-12-31
Not applicable
Canada
Chlordiazepoxide and Amitriptyline HCl
Chlordiazepoxide
(10 mg/1)
+
Amitriptyline hydrochloride
(25 mg/1)
Tablet
Oral
Par Pharmaceutical
1988-05-09
1999-07-16
US
Chlordiazepoxide and Amitriptyline HCl
Chlordiazepoxide
(5 mg/1)
+
Amitriptyline hydrochloride
(12.5 mg/1)
Tablet
Oral
Par Pharmaceutical
1988-05-09
1999-07-16
US

### Unapproved/Other Products

Name
Ingredients
Dosage
Route
Labeller
Marketing Start
Marketing End
Region
Image
Chlordiazepoxide Clidinium
Chlordiazepoxide hydrochloride
(5 mg/1)
+
Clidinium Bromide
(2.5 mg/1)
Capsule
Oral
River's Edge Pharmaceuticals, LLC
2009-06-02
2012-03-31
US
Chlordiazepoxide Hydrochloride
Chlordiazepoxide hydrochloride
(10 mg/1)
Capsule
Oral
Remedy Repack
2011-08-04
2011-12-28
US
Chlordiazepoxide Hydrochloride and Clidinium Bromide
Chlordiazepoxide hydrochloride
(5 mg/1)
+
Clidinium Bromide
(2.5 mg/1)
Capsule
Oral
Physicians Total Care, Inc.
1996-06-20
2013-01-15
US
Chlordiazepoxide Hydrochloride and Clidinium Bromide
Chlordiazepoxide hydrochloride
(5 mg/1)
+
Clidinium Bromide
(2.5 mg/1)
Capsule
Oral
Burel Pharmaceuticals, Llc
2016-04-15
2017-03-24
US
Chlordiazepoxide Hydrochloride and Clidinium Bromide
Chlordiazepoxide hydrochloride
(5 mg/1)
+
Clidinium Bromide
(2.5 mg/1)
Capsule
Oral
Breckenridge Pharmaceutical, Inc.
2009-02-01
2011-02-28
US

### ATC Codes

N05BA02 — Chlordiazepoxide
N05BA — Benzodiazepine derivatives
N05B — ANXIOLYTICS
N05 — PSYCHOLEPTICS
N — NERVOUS SYSTEM

### Drug Categories

Adjuvants, Anesthesia
Anti-Anxiety Agents
Benzazepines
Benzodiazepines and benzodiazepine derivatives
Central Nervous System Agents
Central Nervous System Depressants
Cytochrome P-450 CYP3A Substrates
Cytochrome P-450 CYP3A4 Substrates
Cytochrome P-450 CYP3A4 Substrates (strength unknown)
Cytochrome P-450 Substrates
Cytosine Nucleotides
GABA Agents
GABA Modulators
Heterocyclic Compounds, Fused-Ring
Hypnotics and Sedatives
Nervous System
Neurotransmitter Agents
Nucleic Acids, Nucleotides, and Nucleosides
Nucleotides
Psycholeptics
Psychotropic Drugs
Pyrimidine Nucleotides
Pyrimidines
Ribonucleotides
Tranquilizing Agents

### Chemical TaxonomyProvided byClassyfire

Description
This compound belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Benzodiazepines
Sub Class
1,4-benzodiazepines
Direct Parent
1,4-benzodiazepines
Alternative Parents
Imidolactams
/
Benzene and substituted derivatives
/
Aryl chlorides
/
Nitrones
/
Propargyl-type 1,3-dipolar organic compounds
/
Carboxamidines
/
Azacyclic compounds
/
Organopnictogen compounds
/
Organochlorides
/
Organic zwitterions
/
Organic oxides
/
Hydrocarbon derivatives
show 2 more
Substituents
1,4-benzodiazepine
/
Allyl-type 1,3-dipolar organic compound
/
Amidine
/
Aromatic heteropolycyclic compound
/
Aryl chloride
/
Aryl halide
/
Azacycle
/
Benzenoid
/
Carboxylic acid amidine
/
Hydrocarbon derivative
/
Imidolactam
/
Monocyclic benzene moiety
/
Nitrone
/
Organic 1,3-dipolar compound
/
Organic nitrogen compound
/
Organic oxide
/
Organic oxygen compound
/
Organic zwitterion
/
Organochloride
/
Organohalogen compound
/
Organonitrogen compound
/
Organopnictogen compound
/
Propargyl-type 1,3-dipolar organic compound
show 13 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
organochlorine compound, secondary amino compound, N-oxide, benzodiazepine (
CHEBI:3611
)

### Kingdom

Organic compounds

### Super Class

Organoheterocyclic compounds

### Class

Benzodiazepines

### Sub Class

1,4-benzodiazepines

### Direct Parent

1,4-benzodiazepines

### Alternative Parents

Imidolactams
/
Benzene and substituted derivatives
/
Aryl chlorides
/
Nitrones
/
Propargyl-type 1,3-dipolar organic compounds
/
Carboxamidines
/
Azacyclic compounds
/
Organopnictogen compounds
/
Organochlorides
/
Organic zwitterions
/
Organic oxides
/
Hydrocarbon derivatives
show 2 more

### Substituents

1,4-benzodiazepine
/
Allyl-type 1,3-dipolar organic compound
/
Amidine
/
Aromatic heteropolycyclic compound
/
Aryl chloride
/
Aryl halide
/
Azacycle
/
Benzenoid
/
Carboxylic acid amidine
/
Hydrocarbon derivative
/
Imidolactam
/
Monocyclic benzene moiety
/
Nitrone
/
Organic 1,3-dipolar compound
/
Organic nitrogen compound
/
Organic oxide
/
Organic oxygen compound
/
Organic zwitterion
/
Organochloride
/
Organohalogen compound
/
Organonitrogen compound
/
Organopnictogen compound
/
Propargyl-type 1,3-dipolar organic compound
show 13 more

### Molecular Framework

Aromatic heteropolycyclic compounds

### External Descriptors

organochlorine compound, secondary amino compound, N-oxide, benzodiazepine (
CHEBI:3611
)

### Affected organisms

Humans and other mammals

### UNII

6RZ6XEZ3CR

### CAS number

58-25-3

### InChI Key

ANTSCNMPPGJYLG-UHFFFAOYSA-N

### InChI

InChI=1S/C16H14ClN3O/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15/h2-9H,10H2,1H3,(H,18,19)

### Synthesis Reference

Sternbach, L.H.; US. Patent 2,893,992; July 7,1959; assigned to Hoffmann-LaRoche, Inc.

### General References

Skerritt JH, Johnston GA: Enhancement of GABA binding by benzodiazepines and related anxiolytics. Eur J Pharmacol. 1983 May 6;89(3-4):193-8. [
Article
]
Oishi R, Nishibori M, Itoh Y, Saeki K: Diazepam-induced decrease in histamine turnover in mouse brain. Eur J Pharmacol. 1986 May 27;124(3):337-42. [
Article
]
Earley JV, Fryer RI, Ning RY: Quinazolines and 1,4-benzodiazepines. LXXXIX: Haptens useful in benzodiazepine immunoassay development. J Pharm Sci. 1979 Jul;68(7):845-50. [
Article
]
Olive G, Dreux C: [Pharmacologic bases of use of benzodiazepines in pereinatal medicine]. Arch Fr Pediatr. 1977 Jan;34(1):74-89. [
Article
]
Vozeh S: [Pharmacokinetic of benzodiazepines in old age]. Schweiz Med Wochenschr. 1981 Nov 21;111(47):1789-93. [
Article
]
FDA Approved Drug Products: Librax (chlordiazepoxide hydrochloride and clidinium bromide) capsules for oral use [
Link
]
FDA Approved Drug Products: LIMBITROL (chlordiazepoxide and amitriptyline HCI) double strength tablets [
Link
]
DailyMed Label: Chlordiazepoxide hydrochloride Oral Capsules [
Link
]

### External Links

Human Metabolome Database
HMDB0014618
KEGG Drug
D00267
PubChem Compound
2712
PubChem Substance
46505044
ChemSpider
10248513
BindingDB
50007664
RxNav
2356
ChEBI
3611
ChEMBL
CHEMBL451
ZINC
ZINC000019632917
Therapeutic Targets Database
DAP000084
PharmGKB
PA448932
RxList
RxList Drug Page
Drugs.com
Drugs.com Drug Page
PDRhealth
PDRhealth Drug Page
Wikipedia
Chlordiazepoxide

### Human Metabolome Database

HMDB0014618

### KEGG Drug

D00267

### PubChem Compound

2712

### PubChem Substance

46505044

### ChemSpider

10248513

### BindingDB

50007664

### RxNav

2356

### ChEBI

3611

### ChEMBL

CHEMBL451

### ZINC

ZINC000019632917

### Therapeutic Targets Database

DAP000084

### PharmGKB

PA448932

### RxList

RxList Drug Page

### Drugs.com

Drugs.com Drug Page

### PDRhealth

PDRhealth Drug Page

### Wikipedia

Chlordiazepoxide

### MSDS

Download
(74.9 KB)

### Manufacturers

Valeant pharmaceuticals international
Abbott laboratories pharmaceutical products div
Rachelle laboratories inc
Ascot hosp pharmaceuticals inc div travenol laboratories inc
Barr laboratories inc
John j ferrante
Halsey drug co inc
Impax laboratories inc
Ivax pharmaceuticals inc sub teva pharmaceuticals usa
Lederle laboratories div american cyanamid co
Mm mast and co
Mylan pharmaceuticals inc
Parke davis div warner lambert co
Pioneer pharmaceuticals inc
Purepac pharmaceutical co
Roxane laboratories inc
Sandoz inc
Superpharm corp
Teva pharmaceuticals usa inc
Usl pharma inc
Vangard laboratories inc div midway medical co
Watson laboratories inc
West ward pharmaceutical corp
Alra laboratories inc

### Packagers

A-S Medication Solutions LLC
Barr Pharmaceuticals
Cardinal Health
Coupler Enterprises Inc.
Direct Dispensing Inc.
Dispensing Solutions
Diversified Healthcare Services Inc.
H and H Laboratories
Heartland Repack Services LLC
Innoviant Pharmacy Inc.
Kaiser Foundation Hospital
Legacy Pharmaceuticals Packaging LLC
Liberty Pharmaceuticals
Major Pharmaceuticals
Merrell Pharmaceuticals Inc.
Murfreesboro Pharmaceutical Nursing Supply
Mylan
Nucare Pharmaceuticals Inc.
Palmetto Pharmaceuticals Inc.
Par Pharmaceuticals
Patheon Inc.
PCA LLC
PD-Rx Pharmaceuticals Inc.
Pharmedix
Physicians Total Care Inc.
Prepackage Specialists
Prepak Systems Inc.
Qualitest
Remedy Repack
Sandhills Packaging Inc.
Solco Healthcare US LLC
Southwood Pharmaceuticals
Stat Rx Usa
UDL Laboratories
Va Cmop Dallas
Valeant Ltd.

### Dosage Forms

Form
Route
Strength
Capsule
Oral
10 mg
Tablet, sugar coated
Oral
5 mg
Capsule
Oral
25 mg
Capsule
Oral
5 mg
Tablet
Oral
Tablet, film coated
Oral
Capsule
Oral
Capsule
Oral
10 mg/1
Capsule
Oral
25 mg/1
Capsule
Oral
5 mg/1
Capsule, gelatin coated
Oral
Tablet, film coated
Oral
5 mg
Tablet
Oral
20 MG
Tablet, coated
Oral
Capsule
Oral
10 mg / cap
Capsule
Oral
25 mg / cap
Pill
Oral
10 MG
Tablet, sugar coated
Oral
5 mg
Pill
Oral
Tablet, coated
Oral
Tablet, sugar coated
Oral
Capsule, gelatin coated
Oral
10 mg/1
Capsule, gelatin coated
Oral
25 mg/1
Capsule, gelatin coated
Oral
5 mg/1
Tablet, film coated
Oral
25 MG
Capsule
Oral
5 mg / cap
Capsule
Oral
Solution / drops
12 MG/ML

### Prices

Unit description
Cost
Unit
Librax 2.5-5 mg capsule
6.5USD
capsule
Librax capsule
5.78USD
capsule
Librium 25 mg capsule
2.14USD
capsule
Limbitrol DS 10-25 mg tablet
1.93USD
tablet
Librium 10 mg capsule
1.61USD
capsule
Librium 5 mg capsule
0.84USD
capsule
Chlordiazepoxide 25 mg capsule
0.72USD
capsule
ChlordiazePOXIDE HCl 25 mg capsule
0.32USD
capsule
ChlordiazePOXIDE HCl 10 mg capsule
0.31USD
capsule
ChlordiazePOXIDE HCl 5 mg capsule
0.31USD
capsule
Chlordiazepoxide 5 mg capsule
0.2USD
capsule
Apo-Chlordiazepoxide 25 mg Capsule
0.17USD
capsule
Chlordiazepoxide 10 mg capsule
0.14USD
capsule
Apo-Chlordiazepoxide 10 mg Capsule
0.11USD
capsule
Apo-Chlordiazepoxide 5 mg Capsule
0.07USD
capsule
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.

### State

Solid

### Experimental Properties

Property
Value
Source
melting point (°C)
236-236.5
Sternbach, L.H.; US. Patent 2,893,992; July 7,1959; assigned to Hoffmann-LaRoche, Inc.
water solubility
2000 mg/L
YALKOWSKY,SH & DANNENFELSER,RM (1992)
logP
2.44
HANSCH,C ET AL. (1995)
pKa
4.8
MERCK INDEX (1996)

### Predicted Properties

Property
Value
Source
Water Solubility
0.0199 mg/mL
ALOGPS
logP
2.01
ALOGPS
logP
0.19
Chemaxon
logS
-4.2
ALOGPS
pKa (Strongest Acidic)
-2.7
Chemaxon
pKa (Strongest Basic)
7.06
Chemaxon
Physiological Charge
1
Chemaxon
Hydrogen Acceptor Count
3
Chemaxon
Hydrogen Donor Count
1
Chemaxon
Polar Surface Area
50.46 Å
2
Chemaxon
Rotatable Bond Count
1
Chemaxon
Refractivity
87.34 m
3
·mol
-1
Chemaxon
Polarizability
31.22 Å
3
Chemaxon
Number of Rings
3
Chemaxon
Bioavailability
1
Chemaxon
Rule of Five
Yes
Chemaxon
Ghose Filter
Yes
Chemaxon
Veber's Rule
No
Chemaxon
MDDR-like Rule
No
Chemaxon

### Predicted ADMET Features

Property
Value
Probability
Human Intestinal Absorption
+
1.0
Blood Brain Barrier
+
0.9758
Caco-2 permeable
+
0.5868
P-glycoprotein substrate
Substrate
0.6705
P-glycoprotein inhibitor I
Non-inhibitor
0.521
P-glycoprotein inhibitor II
Non-inhibitor
0.7434
Renal organic cation transporter
Non-inhibitor
0.5502
CYP450 2C9 substrate
Non-substrate
0.6991
CYP450 2D6 substrate
Non-substrate
0.9116
CYP450 3A4 substrate
Substrate
0.7408
CYP450 1A2 substrate
Inhibitor
0.7564
CYP450 2C9 inhibitor
Non-inhibitor
0.6038
CYP450 2D6 inhibitor
Non-inhibitor
0.7862
CYP450 2C19 inhibitor
Non-inhibitor
0.5
CYP450 3A4 inhibitor
Inhibitor
0.7067
CYP450 inhibitory promiscuity
High CYP Inhibitory Promiscuity
0.6372
Ames test
Non AMES toxic
0.593
Carcinogenicity
Non-carcinogens
0.7108
Biodegradation
Not ready biodegradable
1.0
Rat acute toxicity
2.8520 LD50, mol/kg
Not applicable
hERG inhibition (predictor I)
Weak inhibitor
0.9198
hERG inhibition (predictor II)
Non-inhibitor
0.8828
ADMET data is predicted using
admetSAR
, a free tool for evaluating chemical ADMET properties. (
23092397
)

### Spectra

Spectrum
Spectrum Type
Splash Key
Predicted GC-MS Spectrum - GC-MS
Predicted GC-MS
splash10-0ce9-3190000000-fd85fc0a63c0f6fa743a
GC-MS Spectrum - CI-B
GC-MS
splash10-0udi-0079000000-a3045f81d776a5127fe9
GC-MS Spectrum - EI-B
GC-MS
splash10-001i-5590000000-a20477457b7e9f8a22ea
LC-MS/MS Spectrum - LC-ESI-QTOF , positive
LC-MS/MS
splash10-001i-0090000000-a293b353926a16c4d11a
MS/MS Spectrum - , positive
LC-MS/MS
splash10-004i-2590000000-965415c5fb9e79098c6d
Predicted 1H NMR Spectrum
1D NMR
Not Applicable
Predicted 13C NMR Spectrum
1D NMR
Not Applicable

### Chromatographic Properties

Collision Cross Sections (CCS)
Adduct
CCS Value (Å
2
)
Source type
Source
[M-H]-
172.553974
predicted
DarkChem Lite v0.1.0
[M-H]-
165.91515
predicted
DeepCCS 1.0 (2019)
[M+H]+
173.028374
predicted
DarkChem Lite v0.1.0
[M+H]+
168.27315
predicted
DeepCCS 1.0 (2019)
[M+Na]+
172.533774
predicted
DarkChem Lite v0.1.0
[M+Na]+
174.87038
predicted
DeepCCS 1.0 (2019)

### Kind

Protein

### Organism

Humans

### Pharmacological action

Unknown

### Actions

Substrate

### Curator comments

Benzodiazepines modulate GABA(A) function by binding at the interface between alpha (α) and gamma (γ) subunits. Of the 6 α-subunits, only 4 (α-1, -2, -3, and -5) participate in the formation of this binding site. The above target is a collection of all α- and γ-subunits that are known to participate in the formation of the benzodiazepine binding site.

### General Function

A cytochrome P450 monooxygenase involved in the metabolism of sterols, steroid hormones, retinoids and fatty acids (PubMed:10681376, PubMed:11093772, PubMed:11555828, PubMed:12865317, PubMed:14559847, PubMed:15373842, PubMed:15764715, PubMed:19965576, PubMed:20702771, PubMed:21490593, PubMed:21576599). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds (PubMed:12865317, PubMed:14559847, PubMed:15373842, PubMed:15764715, PubMed:21490593, PubMed:21576599, PubMed:2732228). Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2-hydroxy E1 and E2, as well as D-ring hydroxylated E1 and E2 at the C-16 position (PubMed:11555828, PubMed:12865317, PubMed:14559847). Plays a role in the metabolism of androgens, particularly in oxidative deactivation of testosterone (PubMed:15373842, PubMed:15764715, PubMed:22773874, PubMed:2732228). Metabolizes testosterone to less biologically active 2beta- and 6beta-hydroxytestosterones (PubMed:15373842, PubMed:15764715, PubMed:2732228). Contributes to the formation of hydroxycholesterols (oxysterols), particularly A-ring hydroxylated cholesterol at the C-4beta position, and side chain hydroxylated cholesterol at the C-25 position, likely contributing to cholesterol degradation and bile acid biosynthesis (PubMed:21576599). Catalyzes bisallylic hydroxylation of polyunsaturated fatty acids (PUFA) (PubMed:9435160). Catalyzes the epoxidation of double bonds of PUFA with a preference for the last double bond (PubMed:19965576). Metabolizes endocannabinoid arachidonoylethanolamide (anandamide) to 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling (PubMed:20702771). Plays a role in the metabolism of retinoids. Displays high catalytic activity for oxidation of all-trans-retinol to all-trans-retinal, a rate-limiting step for the biosynthesis of all-trans-retinoic acid (atRA) (PubMed:10681376). Further metabolizes atRA toward 4-hydroxyretinoate and may play a role in hepatic atRA clearance (PubMed:11093772). Responsible for oxidative metabolism of xenobiotics. Acts as a 2-exo-monooxygenase for plant lipid 1,8-cineole (eucalyptol) (PubMed:11159812). Metabolizes the majority of the administered drugs. Catalyzes sulfoxidation of the anthelmintics albendazole and fenbendazole (PubMed:10759686). Hydroxylates antimalarial drug quinine (PubMed:8968357). Acts as a 1,4-cineole 2-exo-monooxygenase (PubMed:11695850). Also involved in vitamin D catabolism and calcium homeostasis. Catalyzes the inactivation of the active hormone calcitriol (1-alpha,25-dihydroxyvitamin D(3)) (PubMed:29461981)

### Specific Function

1,8-cineole 2-exo-monooxygenase activity

### Gene Name

CYP3A4

### Uniprot ID

P08684

### Uniprot Name

Cytochrome P450 3A4

### Molecular Weight

57342.67 Da

